The increasing demand for ketamine, often for mental health issues, presents complex challenges regarding its sale and secure delivery within the United States. Stringent state guidelines govern such process, demanding adherence from providers. Additionally, ensuring patient confidentiality through meticulous transport protocols and authorized tran